
James Schultz
Examiner (ID: 14322, Phone: (571)272-0763 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1631, 1635 |
| Total Applications | 977 |
| Issued Applications | 385 |
| Pending Applications | 182 |
| Abandoned Applications | 415 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5501645
[patent_doc_number] => 20090162333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/300569
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4394
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162333.pdf
[firstpage_image] =>[orig_patent_app_number] => 12300569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/300569 | PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASES | May 24, 2007 | Abandoned |
Array
(
[id] => 5510660
[patent_doc_number] => 20090083867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/226481
[patent_app_country] => US
[patent_app_date] => 2007-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13652
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20090083867.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226481
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226481 | Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases | Apr 19, 2007 | Abandoned |
Array
(
[id] => 5302962
[patent_doc_number] => 20090297614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'NANOPARTICLES FOR PROVIDING IMMUNE RESPONSES AGAINST INFECTIOUS AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/296973
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9446
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296973 | Nanoparticles for providing immune responses against infectious agents | Apr 12, 2007 | Issued |
Array
(
[id] => 5538648
[patent_doc_number] => 20090220453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'ENHANCING STEM CELL MOBILIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/295680
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14528
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295680
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295680 | Enhancing stem cell mobilization | Apr 4, 2007 | Issued |
Array
(
[id] => 8571464
[patent_doc_number] => 08338108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Agent for promoting the production of thioredoxin'
[patent_app_type] => utility
[patent_app_number] => 12/225415
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5122
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12225415
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225415 | Agent for promoting the production of thioredoxin | Mar 28, 2007 | Issued |
Array
(
[id] => 5546663
[patent_doc_number] => 20090156540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'METHOD FOR DIAGNOSING AND/OR PREDICTING THE DEVELOPMENT OF AN ALLERGIC DISORDER AND AGENTS FOR TREATING AND/OR PREVENTING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/281519
[patent_app_country] => US
[patent_app_date] => 2007-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 28799
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156540.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281519
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281519 | METHOD FOR DIAGNOSING AND/OR PREDICTING THE DEVELOPMENT OF AN ALLERGIC DISORDER AND AGENTS FOR TREATING AND/OR PREVENTING SAME | Mar 6, 2007 | Abandoned |
Array
(
[id] => 5564664
[patent_doc_number] => 20090137517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'SENSITIZING A CELL TO CANCER TREATMENT BY MODULATING THE ACTIVITY OF A NUCLEIC ACID ENCODING RPS27L PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/281423
[patent_app_country] => US
[patent_app_date] => 2007-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11464
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137517.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281423 | SENSITIZING A CELL TO CANCER TREATMENT BY MODULATING THE ACTIVITY OF A NUCLEIC ACID ENCODING RPS27L PROTEIN | Feb 28, 2007 | Abandoned |
Array
(
[id] => 4485702
[patent_doc_number] => 07902353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Nucleic acid enzyme biosensors for ions'
[patent_app_type] => utility
[patent_app_number] => 11/674042
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 14346
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/902/07902353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11674042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/674042 | Nucleic acid enzyme biosensors for ions | Feb 11, 2007 | Issued |
Array
(
[id] => 5112357
[patent_doc_number] => 20070196272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'ORAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 11/673192
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8475
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196272.pdf
[firstpage_image] =>[orig_patent_app_number] => 11673192
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/673192 | ORAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS | Feb 8, 2007 | Abandoned |
Array
(
[id] => 5398476
[patent_doc_number] => 20090318539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Process for Preparing a Particle Comprising a Biological Molecule and a Carrier Polymer'
[patent_app_type] => utility
[patent_app_number] => 12/278855
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7595
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278855
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278855 | Process for preparing a particle comprising a biological molecule and a carrier polymer | Feb 7, 2007 | Issued |
Array
(
[id] => 4658090
[patent_doc_number] => 20080026952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'HCV replicon shuttle vectors'
[patent_app_type] => utility
[patent_app_number] => 11/641339
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7009
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11641339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/641339 | HCV replicon shuttle vectors | Dec 17, 2006 | Abandoned |
Array
(
[id] => 15880531
[patent_doc_number] => 10646590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Methods for phototransfecting nucleic acids into live cells
[patent_app_type] => utility
[patent_app_number] => 12/086471
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 13943
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12086471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086471 | Methods for phototransfecting nucleic acids into live cells | Dec 11, 2006 | Issued |
Array
(
[id] => 8642644
[patent_doc_number] => 08367628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Amphoteric liposome formulation'
[patent_app_type] => utility
[patent_app_number] => 12/085893
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26473
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12085893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085893 | Amphoteric liposome formulation | Nov 30, 2006 | Issued |
Array
(
[id] => 6254238
[patent_doc_number] => 20100028848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Compositions and Methods of Using siRNA to Knockdown Gene Expression and to Improve Solid Organ and Cell Transplantation'
[patent_app_type] => utility
[patent_app_number] => 12/085873
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9252
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028848.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085873
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085873 | Compositions and Methods of Using siRNA to Knockdown Gene Expression and to Improve Solid Organ and Cell Transplantation | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5091663
[patent_doc_number] => 20070231302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Multipotent neural stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/601565
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32817
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231302.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601565
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601565 | Multipotent neural stem cells | Nov 16, 2006 | Issued |
Array
(
[id] => 5080753
[patent_doc_number] => 20070123977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device'
[patent_app_type] => utility
[patent_app_number] => 11/560353
[patent_app_country] => US
[patent_app_date] => 2006-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24061
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123977.pdf
[firstpage_image] =>[orig_patent_app_number] => 11560353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/560353 | Progenitor endothelial cell capturing with a drug eluting implantable medical device | Nov 14, 2006 | Issued |
Array
(
[id] => 5558907
[patent_doc_number] => 20090270484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'WWOX Vectors and Uses in Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/083067
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5166
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270484.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083067 | WWOX Vectors and Uses in Treatment of Cancer | Oct 3, 2006 | Abandoned |
Array
(
[id] => 8981565
[patent_doc_number] => 08512678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Non-invasive, in vivo fluorescent imaging of the nervous system in whole living animal'
[patent_app_type] => utility
[patent_app_number] => 11/990029
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 13498
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11990029
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990029 | Non-invasive, in vivo fluorescent imaging of the nervous system in whole living animal | Sep 26, 2006 | Issued |
Array
(
[id] => 5514272
[patent_doc_number] => 20090214578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone'
[patent_app_type] => utility
[patent_app_number] => 11/992080
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18202
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992080
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992080 | Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone | Sep 14, 2006 | Abandoned |
Array
(
[id] => 5545302
[patent_doc_number] => 20090155179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'KINETIC BIOMARKER FOR QUANTIFICATION OF LYMPHOPROLIFERATION, CLONAL EXPANSION, RECRUITMENT AND TRAFFICKING IN LYMPHOID TISSUES AND OF THE IN VIVO ACTIONS OF ANTIGENS AND MODULATING THEREON'
[patent_app_type] => utility
[patent_app_number] => 12/065890
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24462
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065890
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065890 | KINETIC BIOMARKER FOR QUANTIFICATION OF LYMPHOPROLIFERATION, CLONAL EXPANSION, RECRUITMENT AND TRAFFICKING IN LYMPHOID TISSUES AND OF THE IN VIVO ACTIONS OF ANTIGENS AND MODULATING THEREON | Sep 5, 2006 | Abandoned |